Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Ettinger

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Bioinformatics (Oxford, England)|April 6, 2002
The complexity of comparing reaction systemsMark Ettinger
The American Journal of Medicine|March 28, 2006
Improving compliance and persistence with bisphosphonate therapy for osteoporosisRonald D Emkey, Mark Ettinger
Clinical Drug Investigation|May 23, 2007
Weekly oral alendronic Acid in male osteoporosisPaul D Miller, Thomas Schnitzer, Ronald Emkey, et al.
Menopause (New York, N.Y.)|June 1, 2006
Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifeneMichael R McClung, Ethel Siris, Steve Cummings, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Bioinformatics (Oxford, England)|April 6, 2002
The complexity of comparing reaction systemsMark Ettinger
The American Journal of Medicine|March 28, 2006
Improving compliance and persistence with bisphosphonate therapy for osteoporosisRonald D Emkey, Mark Ettinger
Clinical Drug Investigation|May 23, 2007
Weekly oral alendronic Acid in male osteoporosisPaul D Miller, Thomas Schnitzer, Ronald Emkey, et al.
Menopause (New York, N.Y.)|June 1, 2006
Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifeneMichael R McClung, Ethel Siris, Steve Cummings, et al.
Pageof 1